Drivers of Multi-Drug Resistance to Anti-Tuberculosis Drugs in TB/HIV Co-Infection in Tuberculosis Patients

TB/HIV co-infection is a very heavy burden, and controlling or even eliminating it is a challenge for African countries and their health services. The leading cause of mortality for those with TB/HIV co-infection is still resistance to anti-tuberculosis medications, and the factors leading to it are little known because they are less documented. The main aim of this research was to determine the drivers of multi-drug resistance to anti-tuberculosis drugs in TB/HIV co-infection in tuberculosis pa